Monitoring Treatment: Clinical and Programmatic Approach for Drug-Susceptible and Drug-Resistant Tuberculosis

Jan-Willem C Alffenaar; Hannah Yejin Kim; Anthony Byrne; Alberto Piubello; Giovanni Battista Migliori

doi:10.1007/978-3-030-66703-0_18

Monitoring Treatment: Clinical and Programmatic Approach for Drug-Susceptible and Drug-Resistant Tuberculosis

Jan-Willem C Alffenaar, Hannah Yejin Kim, Anthony Byrne, Alberto Piubello, Giovanni Battista Migliori

Pharmacy

Research output: Chapter in Book/Report/Conference proceeding › Chapter › Research › peer-review

Abstract

Tuberculosis (TB) treatment management of patients becomes more difficult with increasing drug resistance. Monitoring of TB treatment is therefore of utmost importance to increase the success rate and prevent complications. This chapter provides an overview of the most critical microbiological, clinical and drug-related parameters at the start and during the treatment of tuberculosis. Therapeutic drug monitoring has been recommended in order to further minimize drug-related adverse reactions and optimize treatment response. An approach on how to include personalized management in programmatic treatment is included.

Original language	English
Title of host publication	Essential Tuberculosis
Editors	Giovanni Battista Migliori, Mario C. Raviglione
Place of Publication	Switzerland
Pages	163-170
Edition	1
DOIs	https://doi.org/10.1007/978-3-030-66703-0_18
Publication status	Published - 27 Jul 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1007/978-3-030-66703-0_18

https://hdl.handle.net/1959.11/73485

Handle.net

Persistent link

Cite this

@inbook{ad1d036f50f543cda3171804b84d5748,

title = "Monitoring Treatment: Clinical and Programmatic Approach for Drug-Susceptible and Drug-Resistant Tuberculosis",

abstract = "Tuberculosis (TB) treatment management of patients becomes more difficult with increasing drug resistance. Monitoring of TB treatment is therefore of utmost importance to increase the success rate and prevent complications. This chapter provides an overview of the most critical microbiological, clinical and drug-related parameters at the start and during the treatment of tuberculosis. Therapeutic drug monitoring has been recommended in order to further minimize drug-related adverse reactions and optimize treatment response. An approach on how to include personalized management in programmatic treatment is included.",

author = "Alffenaar, \{Jan-Willem C\} and Kim, \{Hannah Yejin\} and Anthony Byrne and Alberto Piubello and Migliori, \{Giovanni Battista\}",

year = "2021",

month = jul,

day = "27",

doi = "10.1007/978-3-030-66703-0\_18",

language = "English",

isbn = "9783030667054",

pages = "163--170",

editor = "Migliori, \{Giovanni Battista\} and Raviglione, \{Mario C.\}",

booktitle = "Essential Tuberculosis",

edition = "1",

}

Monitoring Treatment: Clinical and Programmatic Approach for Drug-Susceptible and Drug-Resistant Tuberculosis. / Alffenaar, Jan-Willem C; Kim, Hannah Yejin; Byrne, Anthony et al.
Essential Tuberculosis. ed. / Giovanni Battista Migliori; Mario C. Raviglione. 1. ed. Switzerland, 2021. p. 163-170.

Research output: Chapter in Book/Report/Conference proceeding › Chapter › Research › peer-review

TY - CHAP

T1 - Monitoring Treatment

T2 - Clinical and Programmatic Approach for Drug-Susceptible and Drug-Resistant Tuberculosis

AU - Alffenaar, Jan-Willem C

AU - Kim, Hannah Yejin

AU - Byrne, Anthony

AU - Piubello, Alberto

AU - Migliori, Giovanni Battista

PY - 2021/7/27

Y1 - 2021/7/27

N2 - Tuberculosis (TB) treatment management of patients becomes more difficult with increasing drug resistance. Monitoring of TB treatment is therefore of utmost importance to increase the success rate and prevent complications. This chapter provides an overview of the most critical microbiological, clinical and drug-related parameters at the start and during the treatment of tuberculosis. Therapeutic drug monitoring has been recommended in order to further minimize drug-related adverse reactions and optimize treatment response. An approach on how to include personalized management in programmatic treatment is included.

AB - Tuberculosis (TB) treatment management of patients becomes more difficult with increasing drug resistance. Monitoring of TB treatment is therefore of utmost importance to increase the success rate and prevent complications. This chapter provides an overview of the most critical microbiological, clinical and drug-related parameters at the start and during the treatment of tuberculosis. Therapeutic drug monitoring has been recommended in order to further minimize drug-related adverse reactions and optimize treatment response. An approach on how to include personalized management in programmatic treatment is included.

UR - https://doi.org/10.1007/978-3-030-66703-0

U2 - 10.1007/978-3-030-66703-0_18

DO - 10.1007/978-3-030-66703-0_18

M3 - Chapter

SN - 9783030667054

SN - 9783030667030

SP - 163

EP - 170

BT - Essential Tuberculosis

A2 - Migliori, Giovanni Battista

A2 - Raviglione, Mario C.

CY - Switzerland

ER -

Monitoring Treatment: Clinical and Programmatic Approach for Drug-Susceptible and Drug-Resistant Tuberculosis

Abstract

UN SDGs

Access to Document

Handle.net

Fingerprint

Cite this